<code id='F3892FD8D5'></code><style id='F3892FD8D5'></style>
    • <acronym id='F3892FD8D5'></acronym>
      <center id='F3892FD8D5'><center id='F3892FD8D5'><tfoot id='F3892FD8D5'></tfoot></center><abbr id='F3892FD8D5'><dir id='F3892FD8D5'><tfoot id='F3892FD8D5'></tfoot><noframes id='F3892FD8D5'>

    • <optgroup id='F3892FD8D5'><strike id='F3892FD8D5'><sup id='F3892FD8D5'></sup></strike><code id='F3892FD8D5'></code></optgroup>
        1. <b id='F3892FD8D5'><label id='F3892FD8D5'><select id='F3892FD8D5'><dt id='F3892FD8D5'><span id='F3892FD8D5'></span></dt></select></label></b><u id='F3892FD8D5'></u>
          <i id='F3892FD8D5'><strike id='F3892FD8D5'><tt id='F3892FD8D5'><pre id='F3892FD8D5'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:73126
          George Yancopoulos on the 2024 Breakthrough Summit East stage.
          George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

          George Yancopoulos is in touch with his teenage self.

          After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

          advertisement

          “My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          STAT Virtual Event: The State of Biosimilars: What to Watch
          STAT Virtual Event: The State of Biosimilars: What to Watch

          Editor’snote:Arecordingoftheeventisembeddedbelow.NowthatbiosimilarversionsofHumiraarestartingtoarriv

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Custom gene therapy hints at new path for rare disease treatments

          AdobeWhenTimothyYudevelopedmilasen,acustomdrugforayounggirlnamedMilawithBattendisease,heignitedaspar